Ingevity Corp
About Ingevity Corp
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.2B
- Net income
- -$167.1M
- Total assets
- $1.7B
- Market cap
- $2.3B
- Gross margin
- 39.5%
- Operating margin
- 35.9%
- Net margin
- -14.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.2B
- Cost of revenue
- $706.1M
- Gross profit
- $461.5M
- Operating expenses
- $42.8M
- Operating income
- $418.7M
- Income tax
- $8.2M
- Net income
- -$167.1M
- EPS (basic)
- $-4.61
- EPS (diluted)
- $-4.61
Balance sheet
- Total assets
- $1.7B
- Current assets
- $454.2M
- Total liabilities
- $1.6B
- Current liabilities
- $341.3M
- Shareholders’ equity
- $29.7M
Cash flow
- Operating cash flow
- $331.2M
- Investing cash flow
- -$57.5M
- Financing cash flow
- -$252.2M
- Net cash flow
- $26.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $2.3B
- EPS (diluted)
- $-4.61
- Shares outstanding
- 34.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 2, 2016
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $167.1M in FY2025.
- Revenue declined 4% from FY2020 to FY2025.
- Gross margin of 39.5%, net margin -14.3%.
- Trading 14% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Ingevity Corp.
Write a review
News about Ingevity Corp
News & sentiment via Polygon.io
